VRCA compared with SHIM: revenue, margins and what each company keeps, and the suppliers and customers both name

VRCAVerrica Pharmaceuticals Inc.

Mkt capRevenueRevenue

SHIMShimmick Corp

Mkt capRevenueRevenue

Compare

VRCAVerrica Pharmaceuticals Inc.

SHIMShimmick Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VRCA1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−5.22%—

SHIM1 of 4 reports

Reportimpliedrealized× implied

Aug 11 '26—▼−6.19%—

= impliedVRCA realized, solidSHIM realized, hatchedOne scale, both sides: full bar = 7%× = |realized| ÷ impliedSource: market data

VRCAVerrica Pharmaceuticals Inc.

3.30▼−3.51%· post 3.40

Mkt cap$57.5MRevenue$6MQ2 FY26Revenue$36MFY25

SHIMShimmick Corp

2.54▼−1.17%· post 2.54

ClosedOct 30 '26

Mkt cap$103.8MRevenue$142MQ3 FY26Revenue$633MFY23

Compare

ClosedOct 30 '26

VRCAVerrica Pharmaceuticals Inc.

SHIMShimmick Corp

3.30▼−3.51%post 3.40

Price

2.54▼−1.17%post 2.54

$57.5M

Mkt cap

$103.8M

Q2 FY26$6M

Revenue

$142MQ3 FY26

FY25$36M

Revenue

$633MFY23

VRCA3.30▼−3.51%vsSHIM2.54▼−1.17%ClosedOct 30 '26